{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T05:50:17Z","timestamp":1725169817719},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDD"],"published-print":{"date-parts":[[2008,10,1]]},"DOI":"10.2174\/156720108785915050","type":"journal-article","created":{"date-parts":[[2008,9,30]],"date-time":"2008-09-30T21:46:46Z","timestamp":1222811206000},"page":"243-247","source":"Crossref","is-referenced-by-count":9,"title":["Pro-Drugs for Indirect Cannabinoids as Therapeutic Agents"],"prefix":"10.2174","volume":"5","author":[{"given":"John","family":"Ashton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/67771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T03:22:57Z","timestamp":1448248977000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1567-2018&volume=5&issue=4&spage=243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/156720108785915050","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}